Strikingly, Glul-KO mice displayed a significantly increased tumor burden (Figure 1D) and reduced survival, with a median survival of approximately 8.4 weeks in WT mice and 5.7 weeks in Glul-KO mice (Figure 1E). The gene discussed is GLUL; the disease is neoplasm.